Puma Biotechnology Financial Ratios Analysis

Valuation, profitability, leverage, and liquidity ratios

Scroll to see more
BreakdownFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Valuation Ratios
P/E Ratio4.959.5498021.07
Forward P/E11.6210.5733.92
P/S Ratio0.650.870.860.491.81
P/B Ratio1.633.859.07-50.81-68.55
Price/Tangible Book3.65
Price/FCF3.857.676.02561.16
Price/OCF3.857.636.02527.76
Enterprise Value Ratios
EV/Revenue0.600.991.020.611.86
EV/EBITDA3.285.215.7412.22
EV/EBIT4.507.017.58119.31
EV/FCF3.598.687.45577.31
Profitability & Returns
Return on Equity (ROE)0.42%0.58%0.00%-10.42%
Return on Assets (ROA)0.09%0.09%0.09%0.00%-0.08%
Return on Invested Capital (ROIC)0.46%0.51%0.00%0.05%-1.28%
Return on Capital Employed (ROCE)0.26%0.25%0.21%0.01%-0.23%
Leverage & Solvency Ratios
Debt/Equity0.802.095.29-47.69-20.32
Debt/EBITDA1.612.272.546.78
Debt/FCF1.914.155.65166.37
Liquidity Ratios
Current Ratio1.541.571.731.281.28
Quick Ratio1.381.451.591.051.04
Efficiency Ratios
Asset Turnover1.041.041.021.070.94
Inventory Turnover8.1510.809.4712.0611.89
Yield & Distribution Ratios
Earnings Yield0.20%0.10%0.00%-0.23%-0.15%
FCF Yield0.26%0.13%-0.08%0.17%0.00%
Buyback Yield-0.03%-0.06%-0.11%-0.03%-0.02%